Bonton Pharmaceuticals Private Limited
About Bonton Pharmaceuticals Private Limited
Data last updated:
Bonton Pharmaceuticals Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 October 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85120MP1999PTC013810. Its GSTIN is 09AABCB6409Q1Z8 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.81 Lakh. It is led by directors Renu Singh and Aditya Pratap Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Behind B. C. Automobiles Kampoo Lashkar, Gwalior, Madhya Pradesh, India – 474009.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.4 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹5,448 (net margin 0.2%) and EBITDA of ₹92,690 (EBITDA margin 4.1%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹8 Lakh and satisfied charges of ₹2 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bonton Pharmaceuticals Private Limited's registered office is in Gwalior, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBehind B. C. Automobiles Kampoo Lashkar, Gwalior, Madhya Pradesh, India – 474009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bonton Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bonton Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bonton Pharmaceuticals Private Limited, buy the company report.
Financials of Bonton Pharmaceuticals Private Limited
FY 2024 filings availableBonton Pharmaceuticals Private Limited reported revenue of ₹22.4 Lakh (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 10% fall in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹92,690 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,448 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bonton Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bonton Pharmaceuticals Private Limited
Bonton Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renu Singh | Director | 21 Oct 1999 | 27 Years 0 Months | Current |
| Aditya Pratap Singh | Director | 21 Oct 1999 | 27 Years 0 Months | Current |
Auditor
Bonton Pharmaceuticals Private Limited is audited by AGARWAL & TULSYAN for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL & TULSYAN | FY 2023 | 0016529C |
Shareholding
The shareholding of Bonton Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bonton Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Apr 2018 | 100177354 | Others | ₹8 Lakh | Open | |
| 01 Jun 2001 | 90203824 | Dena Bank | ₹2 Lakh | Satisfied |
To see the full charge records of Bonton Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Bonton Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bonton Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bonton Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCB6409Q1Z8 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bonton Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bonton Pharmaceuticals Private Limited has 4 board changes on record since 1999: 2 appointments and 2 cessations. The latest: Neeraj Kumar ceased to be Director on 20 Apr 2012.
Frequently asked questions
Bonton Pharmaceuticals is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 October 1999 (27+ years old) and is registered under CIN U85120MP1999PTC013810.
Bonton Pharmaceuticals has 2 current directors:
- Renu Singh - Director
- Aditya Pratap Singh - Director
The latest financial statements of Bonton Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Bonton Pharmaceuticals is 09AABCB6409Q1Z8, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Bonton Pharmaceuticals is U85120MP1999PTC013810. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bonton Pharmaceuticals was incorporated on 21 October 1999, making it 27+ years old. It is registered with the Registrar of Companies, Gwalior.
Neeraj Kumar ceased to be Director on 20 Apr 2012. Kunwar Pratap Bhan Singh ceased to be Director on 29 Sep 2008. Aditya Pratap Singh was appointed as Director on 21 Oct 1999. Bonton Pharmaceuticals has 4 board changes on record in total.
The registered office of Bonton Pharmaceuticals is at Behind B. C. Automobiles Kampoo Lashkar, Gwalior, Madhya Pradesh, India – 474009.
Bonton Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Bonton Pharmaceuticals has open charges of ₹8 Lakh and satisfied charges of ₹2 Lakh as per latest MCA filings.